NCT00075049View on ClinicalTrials.gov

Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions

Malaria

Interventions

BIOLOGICAL

RTS,S with AS02A/AS01B adjuvant

Trial Locations (1)

20910

Walter Reed Army Institute of Research, Silver Spring

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

U.S. Army Medical Research and Development Command

FED